Table 1

Specificity and sensitivity of serum CEA and CA 15.3 levels in patients with breast disease

StageNo. of patientsSerum marker levelsa
CEA (>5 ng/ml)CA 15.3 (>30 units/ml)
Benign73821 (2.9)58 (7.9)
Malignant
 I39225 (6.4)48 (12.2)
 II56263 (11.2)124 (22.1)
 III15335 (22.9)56 (36.6)
 IV4812 (25.0)30 (62.5)
 Metastatic disease24099 (41.3)194 (80.8)
 Local recurrence588 (13.8)28 (48.3)
Total1453242 (16.7)480 (33.0)
  • a Numbers in parentheses represent percentages.